{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:47Z","timestamp":1793301167553,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.schres.2023.10.027","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T16:15:56Z","timestamp":1700324156000},"page":"118-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database"],"prefix":"10.1016","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-1224","authenticated-orcid":false,"given":"Renato","family":"de Filippis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5742-905X","authenticated-orcid":false,"given":"Carlos","family":"De las Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6788-4435","authenticated-orcid":false,"given":"Emilio J.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-4117","authenticated-orcid":false,"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-5646","authenticated-orcid":false,"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-2314","authenticated-orcid":false,"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2023.10.027_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/cap.2021.0092","article-title":"Clozapine for management of childhood and adolescent-onset schizophrenia: a systematic review and meta-analysis","volume":"32","author":"Adnan","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2125.2003.01858.x","article-title":"Identification of a novel splice-site mutation in the CYP1A2 gene","volume":"6","author":"Allorge","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.psychres.2019.07.008","article-title":"A comparative study of detection of myocarditis induced by clozapine: with and without cardiac monitoring","volume":"279","author":"An\u0131l Ya\u011fc\u0131o\u011flu","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.rpsm.2022.06.001","article-title":"A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels","volume":"15","author":"Arrojo-Romero","year":"2022","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.schres.2023.10.027_bb0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00002018-200831100-00002","article-title":"Drug-induced pancreatitis: incidence, management and prevention","volume":"31","author":"Balani","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.schres.2023.10.027_bb0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1994.tb04385.x","article-title":"Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test","volume":"38","author":"Bertilsson","year":"1994","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0028-1094343","article-title":"Temperaturanstiege und Bluteiwei\u03b2ver\u00e4nderungen unter der Therapie mit Neuroleptika-unter besonderer Ber\u00fccksichtigung des neuartigen Dibenzodiazepin-Derivates Clozapin","volume":"5","author":"Blum","year":"1972","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/1044546041649039","article-title":"Pericarditis and polyserositis as a side effect of clozapine in an adolescent girl","volume":"14","author":"Branik","year":"2004","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.09.019","article-title":"A 12-month audit of clozapine associated myocarditis in a South Australian local health network: the importance of screening and personalised titration","author":"Carswell","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0055","first-page":"158","article-title":"Valproic acid-induced acute pancreatitis in pediatric age: case series and review of literature","volume":"36","author":"Cofini","year":"2015","journal-title":"G. Chir."},{"key":"10.1016\/j.schres.2023.10.027_bb0060","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4088\/JCP.v60n1019","article-title":"Adding other antipsychotics to clozapine","volume":"60","author":"Cooke","year":"1999","journal-title":"J. Clin. Pychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1574886314666191004092520","article-title":"Drug withdrawal due to safety: a review of the data supporting withdrawal decision","volume":"15","author":"Craveiro","year":"2020","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.schres.2023.10.027_bb0070","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.09l05692yel","article-title":"Clozapine rechallenge following clozapine- induced pericarditis","volume":"71","author":"Crews","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/JCP.0000000000001339","article-title":"Successful clozapine rechallenge after suspected clozapine-associated myocarditis: a case report","volume":"41","author":"Danilewitz","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/17512433.2020.1787831","article-title":"Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"13","author":"de Filippis","year":"2020","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0085","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/02698811211021587","article-title":"Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: a systematic review","volume":"35","author":"de Filippis","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2022.04.009","article-title":"Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases","volume":"60","author":"de Filippis","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/17425255.2022.2160318","article-title":"Clozapine-associated myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review","volume":"18","author":"De Las Cuevas","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.schres.2023.10.027_bb0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.rpsm.2021.07.004","article-title":"Clozapine-associated myocarditis in the World Health Organization\u2019s pharmacovigilance database: focus on reports from various countries","volume":"15","author":"De Las Cuevas","year":"2022","journal-title":"Rev. Psiquiatr. Salud Ment."},{"key":"10.1016\/j.schres.2023.10.027_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17512433.2022.2032659","article-title":"Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase","volume":"15","author":"De Las Cuevas","year":"2022","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0110","article-title":"Adverse drug reactions and their fatal outcomes in clozapine-treated patients in VigiBase: comparing the top four reporting countries (US, UK, Canada and Australia)","author":"De las Cuevas","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/bcp.12659","article-title":"Phenoconversion and therapeutic drug monitoring","volume":"80","author":"de Leon","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/FTD.0000000000000705","volume":"42","author":"de Leon","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.schres.2023.10.027_bb0125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.24869\/psyd.2022.411","article-title":"Reflections on the complex history of the concept of clozapine-associated inflammation during titration","volume":"34","author":"de Leon","year":"2022","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.schres.2023.10.027_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.30773\/pi.2022.0293","article-title":"Reflections on the lack of consideration of ethnic ancestry to stratify clozapine dosing","volume":"20","author":"de Leon","year":"2023","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.schres.2023.10.027_bb0135","series-title":"Australian (and other) psychiatrists should falsify the theory that slow personalized titrations using CRP monitoring substantially decrease the high rates and mortality of clozapine-associated myocarditis in Australia (and some other countries)","author":"de Leon","year":"2024"},{"key":"10.1016\/j.schres.2023.10.027_bb0140","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0278-5846(03)00148-9","article-title":"Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report","volume":"27","author":"de Leon","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000507638","article-title":"A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology","volume":"89","author":"de Leon","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.schres.2023.10.027_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12384","article-title":"Using therapeutic drug monitoring to personalize clozapine dosing in Asians","volume":"12","author":"de Leon","year":"2020","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.psym.2019.08.008","article-title":"Rapid titration and decreased clozapine clearance may help explain five cases of clozapine-induced myocarditis in a New York hospital","volume":"61","author":"de Leon","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2023.10.027_bb0160","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00406-022-01407-7","article-title":"An international clozapine titration guideline to increase its safety and move forward on the route started by German-speaking psychiatrists in the 1960s","volume":"272","author":"de Leon","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2023.10.027_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/a-1625-6388","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels","volume":"55","author":"de Leon","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0170","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(00)00035-0","article-title":"Clozapine and sudden death","volume":"355","author":"Devarajan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.10.027_bb0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2007-1004591","article-title":"Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables","volume":"4","author":"Diaz","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0180","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/JCP.0000000000000926","article-title":"The effect of body weight changes on total plasma clozapine concentrations determined by applying a statistical model to the data from a double-blind trial","volume":"38","author":"Diaz","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rpsm.2021.10.003","article-title":"Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-associated myocarditis: a re-analysis of a Turkish case series","volume":"15","author":"Ertu\u011frul","year":"2022","journal-title":"Rev. Psiquiatr. Salud Ment. (Engl Ed)."},{"key":"10.1016\/j.schres.2023.10.027_bb0190","series-title":"The dropped-head syndrome: a possible new variant of clozapine-induced inflammation during titration","author":"Escobedo-Aedo","year":"2023"},{"key":"10.1016\/j.schres.2023.10.027_bb0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0140-6736(92)90526-9","article-title":"Eosinophilia, clozapine, and pancreatitis","volume":"340","author":"Frankenburg","year":"1992","journal-title":"Lancet"},{"issue":"Suppl S97-100","key":"10.1016\/j.schres.2023.10.027_bb0200","article-title":"Side effects of clozapine","volume":"99","author":"Gaertner","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2023.10.027_bb0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00535-006-1961-4","article-title":"Valproic acid-induced pancreatitis: 16 new cases and a review of the literature","volume":"42","author":"Gerstner","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.schres.2023.10.027_bb0210","first-page":"321","article-title":"Neuroleptikanebenwirkungen mit Schwerpunkt Gewichtszunahme [Neuroleptic adverse effects with emphasis on weight gain]","volume":"37","author":"Hebebrand","year":"2009","journal-title":"Z. Kinder Jugendpsychiatr. Psychother."},{"issue":"Suppl","key":"10.1016\/j.schres.2023.10.027_bb0215","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1007\/BF00442566","article-title":"Clinical experience with clozapine in Germany","volume":"99","author":"Helmchen","year":"1989","journal-title":"Psychopharmacology"},{"issue":"23","key":"10.1016\/j.schres.2023.10.027_bb0220","article-title":"Clozapine in treatment-resistant schizophrenia: who designed that famous US clinical trial?","volume":"S0920-9964","author":"Honigfeld","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0225","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(75)90206-8","article-title":"Clozapine and agranulocytosis","volume":"306","author":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.10.027_bb0230","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.schres.2023.10.027_bb0235","series-title":"A systematic review of clozapine concentration-dose ratio from therapeutic drug monitoring studies in children and adolescents treated with clozapine for mental disorders","author":"Jim\u00e9nez-Fern\u00e1ndez","year":"2023"},{"key":"10.1016\/j.schres.2023.10.027_bb0240","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.09.029","article-title":"Association between initial pattern of clozapine titration, concentration-to- dose ratio, and incidence of fever in patients with schizophrenia spectrum disorders in a Korean tertiary hospital","author":"Kang","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.09.029","article-title":"Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital","author":"Kang","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1440-1614.2002.0988f.x","article-title":"Clozapine associated pericarditis and elevated troponin I","volume":"36","author":"Kay","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2023.06.003","article-title":"Slower clozapine titration than the official Japanese protocol led to fewer inflammatory adverse effects: a retrospective chart review of seven hospitals","author":"Kikuchi","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0265","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.10.027_bb0270","first-page":"29","article-title":"Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases","volume":"24","author":"Koenig","year":"2022","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.schres.2023.10.027_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/phar.2887","article-title":"A systematic review of clozapine-associated inflammation and related monitoring","author":"Leung","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.schres.2023.10.027_bb0280","article-title":"A case series of clozapine titrations affected by inflammatory processes","author":"Leung","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0285","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/0004867416631830","article-title":"Pancreatitis associated with metformin used for management of clozapine-related weight gain","volume":"50","author":"McFadden","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0290","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.therap.2018.08.001","article-title":"What is pharmacoepidemiology? Definition, methods, interest and clinical applications","volume":"74","author":"Montastruc","year":"2019","journal-title":"Therapie"},{"issue":"Suppl S73-S76","key":"10.1016\/j.schres.2023.10.027_bb0295","article-title":"Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia\u2014a retrospective study of 387 patients","volume":"99","author":"Naber","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2023.10.027_bb0300","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/JCP.0000000000001193","article-title":"Implementation and outcomes of a clozapine-associated myocarditis screening program in a region of South Australia-lessons learned","volume":"40","author":"Nachmani Major","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0305","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.schres.2023.10.027_bb0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0962280211403604","article-title":"Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery","volume":"22","author":"Nor\u00e9n","year":"2013","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0315","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00228-002-0486-x","article-title":"Bacterial pneumonia can increase serum concentration of clozapine","volume":"58","author":"Raaska","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0320","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1097\/MJT.0000000000000894","article-title":"Off-label use of clozapine in children and adolescents-a literature review","volume":"26","author":"Rachamallu","year":"2019","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.schres.2023.10.027_bb0325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.psym.2018.07.009","article-title":"Thirty years of both ignorance and clinical experience suggest that clozapine intoxication during co-occurring infections and inflammation may have higher morbidity and mortality than is currently believed","volume":"60","author":"Ruan","year":"2019","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2023.10.027_bb0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2217\/pgs-2020-0015","article-title":"Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?","volume":"21","author":"Ruan","year":"2020","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.schres.2023.10.027_bb0335","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/0091217417749799","article-title":"Two cases of high serum clozapine concentrations occurring during inflammation in Chinese patients","volume":"53","author":"Ruan","year":"2018","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.schres.2023.10.027_bb0340","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/JCP.0000000000001125","article-title":"Exploring the prevalence of clozapine phenotypic poor metabolizers in 4 Asian samples: they ranged between 2% and 13","volume":"39","author":"Ruan","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/JCP.0000000000001018","article-title":"Clozapine metabolism in East Asians and Caucasians: a pilot exploration of the prevalence of poor metabolizers and a systematic review","volume":"39","author":"Ruan","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0350","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000506355","article-title":"Around 3% of 1,300 levels were elevated during infections in a retrospective review of 131 Beijing Hospital in-patients with more than 24,000 days of clozapine treatment","volume":"89","author":"Ruan","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.schres.2023.10.027_bb0355","article-title":"Exploring low clozapine C\/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients. A literature review and a case series of 17 patients from 3 studies","author":"Ruan","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0360","first-page":"1","article-title":"Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia","volume":"29","author":"Schneider","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0365","doi-asserted-by":"crossref","first-page":"22ac14500","DOI":"10.4088\/JCP.22ac14500","article-title":"Best practices for starting clozapine in patients with schizophrenia: how to switch from the prior antipsychotic(s)","volume":"83","author":"Schoretsanitis","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0370","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/JCP.0000000000001202","article-title":"Adding oral contraceptives to clozapine may require halving the clozapine dose: a new case and a literature review","volume":"40","author":"Schoretsanitis","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0375","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/17425255.2022.2106214","article-title":"Drug-drug interactions between psychotropic medications and oral contraceptives","volume":"18","author":"Schoretsanitis","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.schres.2023.10.027_bb0380","first-page":"186","article-title":"Sodium diphenylhydantoin as a probable cause of pancreatitis","volume":"64","author":"Sep\u00falveda Vild\u00f3sola","year":"1999","journal-title":"Rev. Gastroenterol. Mex."},{"key":"10.1016\/j.schres.2023.10.027_bb0385","first-page":"153","article-title":"Should we routinely add CRP to clozapine titrations? - learning from three cases","volume":"24","author":"Shelton","year":"2022","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.schres.2023.10.027_bb0390","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40264-022-01204-0","article-title":"Pancreas and adverse drug reactions: a literature review","volume":"45","author":"Sosnowski","year":"2022","journal-title":"Drug Saf."},{"key":"10.1016\/j.schres.2023.10.027_bb0395","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/cap.2018.0036","article-title":"A retrospective multicenter evaluation of clozapine use in pediatric patients admitted for acute psychiatric hospitalization","volume":"28","author":"Steinauer","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0400","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00004583-199406000-00005","article-title":"Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome","volume":"33","author":"Towbin","year":"1994","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.schres.2023.10.027_bb0405","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(04)16261-2","article-title":"When are observational studies as credible as randomised trials?","volume":"363","author":"Vandenbroucke","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.10.027_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","article-title":"Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review","volume":"211","author":"Verdoux","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.10.027_bb0415","first-page":"170","article-title":"Pludselig d\u00f8d under behandling med klozapin (Leponex) [Sudden death during treatment with clozapine (Leponex)]","volume":"142","author":"Vesterby","year":"1980","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.schres.2023.10.027_bb0420","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/schbul\/sbad030","article-title":"Clozapine optimization: a Delphi consensus guideline from the treatment response and resistance in Psychosis Working Group","volume":"49","author":"Wagner","year":"2023","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.10.027_bb0425","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00004714-200302000-00017","article-title":"Pancreatitis followed by pericardial effusion in an adolescent treated with clozapine","volume":"23","author":"Wehmeier","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0430","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/1044546041648977","article-title":"Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine","volume":"14","author":"Wehmeier","year":"2004","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0435","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2710.2004.00616_1.x","article-title":"Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine","volume":"30","author":"Wehmeier","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.schres.2023.10.027_bb0440","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2165\/00002018-199614060-00006","article-title":"Drug-induced pancreatitis","volume":"14","author":"Wilmink","year":"1996","journal-title":"Drug Saf."},{"key":"10.1016\/j.schres.2023.10.027_bb0445","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/JCP.0000000000001365","article-title":"All in one: clozapine-associated acute pancreatitis with multiple organ involvement","volume":"41","author":"Yildiz","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.10.027_bb0450","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cpt.690","article-title":"Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale sequencing projects","volume":"102","author":"Zhou","year":"2017","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423003870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423003870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T05:58:53Z","timestamp":1730527133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423003870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":90,"alternative-id":["S0920996423003870"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.10.027","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}